BELLUS Health reports results for first half of f...(l April 7 2011 are paid by way of issuan...),Health

Date:8/11/2009

l April 7, 2011, are paid by way of issuance of Common Shares at an assumed market price of CDN$0.24, and that the lease is terminated pursuant to the First Termination Option, the maximum number of Common Shares issuable under the notes would be 43,365,913, representing a potential dilution factor of 83%, based on the number of Common Shares issued and outstanding as at June 30, 2009.

In May 2009, BELLUS Health issued 1,594,026 Common Shares in payment of interest on the outstanding Amended Notes and in June 2009, BELLUS Health issued 600,000 Common Shares upon conversion of Series A Preferred Shares.

In June 2009, options to purchase an aggregate of 600,000 Common Shares were granted to directors of the Company, options to purchase 410,851 Common Shares and 101,300 Common Shares have been cancelled and expired, respectively.

On January 8, 2009, the Company's common stock was delisted from the NASDAQ Capital Market following the Company's formal notice of its intention to voluntarily delist its common stock provided to the NASDAQ Stock Market, notice to the public by press release and the formal notice provided to the SEC, in December 2008. The decision was taken in light of the continuing, extreme short-term volatility in the financial markets and, accordingly, in the Company's market value. Originally, the Company received a NASDAQ Staff Deficiency Letter dated October 10, 2008, stating that, for 10 consecutive trading days, the market value of the Company's listed securities had been below the minimum $50,000,000 requirement for continued inclusion on the NASDAQ Global Market. The Company filed an application to transfer the listing of its common stock from the NASDAQ Global Market to the NASDAQ Capital Market and the transfer was effective as of November 14, 2008. The Company then received a Deficiency Letter dated December 1, 2008, from the NASDAQ Staff stating that, for 10 consecutive trading days, the market value of the Company's lis
'/>"/>

SOURCE BELLUS HEALTH INC. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
Related medicine news :

1. BELLUS Health Inc. Announces $12 Million Rights Offering To Common Shareholders
2. BELLUS Health reports results for first quarter of fiscal 2009
3. BELLUS announces Chief Financial Officer to depart effective May 22, 2009
4. BELLUS Health inc. announces completion of first tranche of financing
5. BELLUS Health reports results for the fourth quarter of 2008
6. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BELLUS Health Inc.
7. BELLUS Health announces formal notice to voluntarily delist from NASDAQ
8. BELLUS Health is Preparing to Voluntarily Delist from the NASDAQ Capital Market
9. BELLUS Health Announces Stock Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market
10. BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update
11. BELLUS Health to present at the Rodman and Renshaw 10th Annual Healthcare Conference